Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,640 across all filing types
Latest filing 2026-05-17 Notice of Dividend Amou…
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Update - Dividend/Distribution - RMD 4 pages 16.8KB
Notice of Dividend Amount Classification · 92% confidence The document is clearly an Appendix 3A.1 notification detailing a forthcoming dividend/distribution: it specifies the dividend per share, currency conversion rate, record date, ex-date, payment date, withholding tax, and is an update to a previous announcement. This matches the definition of a “Notice of Dividend Amount” (Code: DIV).
2026-05-17 English
4 Statement of changes in beneficial ownership 2 pages 13.6KB
Director's Dealing Classification · 98% confidence The document is a United States SEC Form 4 filing under Section 16(a) of the Exchange Act, which discloses changes in beneficial ownership by an officer/director (Michael J. Farrell, Chairman and CEO). It details personal share and option transactions (insider trades). This matches the “Director's Dealing” category.
2026-05-11 English
144 Report of proposed sale of securities 2 pages 149.6KB
Director's Dealing Classification · 92% confidence The document is an SEC Form 144 “Notice of Proposed Sale of Securities” filed by an officer/director for personal sales of company shares. This is a report of insider share transactions by directors/executives. It fits the Director’s Dealing category (insider trades).
2026-05-10 English
Cessation of Officer Role 2 pages 12.3KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the U.S. Securities and Exchange Commission (SEC), which is a statement of changes in beneficial ownership of company securities by insiders such as officers or directors. It details transactions in the company's stock by Brett Sandercock, the Chief Financial Officer, including the disposal of shares and cessation of officer status due to retirement. Form 4 filings are specifically used to report insider trading activities and changes in ownership by company insiders. This matches the definition of Director's Dealing (DIRS). The document length and content confirm it is not a report or announcement of a report but a regulatory filing of insider transactions.
2026-05-04 English
Appointment of New Officer 1 page 9.9KB
Director's Dealing Classification · 100% confidence The document is a Form 3 filed with the SEC, which is an Initial Statement of Beneficial Ownership of Securities. It reports the ownership of securities by an officer or director of the company. This type of filing is related to insider transactions and ownership disclosures by company insiders. It is not an annual report, earnings release, or any other financial or management report. It specifically reports personal share transactions or holdings by company directors or executives, which matches the definition of Director's Dealing (DIRS). The document length is short and it is a regulatory filing form, but given the specific nature of Form 3, it fits best under Director's Dealing.
2026-05-04 English
Form 10-Q for the Quarter Ended March 31, 2026 52 pages 3.5MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-Q' and is filed with the U.S. Securities and Exchange Commission (SEC). It is explicitly identified as a 'Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934' for the quarterly period ended March 31, 2026. The content includes detailed unaudited condensed consolidated financial statements such as balance sheets, statements of operations, comprehensive income, changes in equity, and cash flows, along with management's discussion and analysis, risk factors, legal proceedings, and other required disclosures. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is the actual quarterly report, not an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2026-05-03 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.